Aethlon medical announces pricing of $4.7 million public offering

San diego , may 15, 2024 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of a public offering of an aggregate of 8,100,000 shares of its common stock (or pre-funded warrants in lieu thereof), class a warrants to purchase up to 8,100,000 shares of common stock, and class b warrants to purchase up to 8,100,000 shares of common stock, at a combined public offering price of $0.58 per share (or pre-funded warrant) and accompanying warrants. the warrants will have an exercise price of $0.58 per share, subject to an adjustment, will be exercisable immediately upon issuance and, in the case of class a warrants, will expire on the fifth anniversary of the original issuance date, and in the case of class b warrants, will expire on the one year anniversary of the original issuance date.
AEMD Ratings Summary
AEMD Quant Ranking